tiprankstipranks
Trending News
More News >
Lineage Cell Therapeutics, Inc. (LCTX)
:LCTX
US Market

Lineage Therap (LCTX) Ownership - Who Owns Lineage Therap?

Compare
1,967 Followers

Lineage Therap (LCTX) Ownership Overview

58.75%6.01%0.02%7.10%28.12%
58.75% Insiders
0.02% Other Institutional Investors
7.10% ETFs
28.12% Public Companies and Individual Investors
The ownership structure of Lineage Therap (LCTX) stock is a mix of institutional, retail, and individual investors. Approximately 13.13% of the company’s stock is owned by Institutional Investors, 58.75% is owned by Insiders, and 28.12% is owned by Public Companies and Individual Investors.
The ownership structure of Lineage Therap (LCTX) stock is a mix of institutional, retail, and individual investors. Approximately 6.03% of the company’s stock is owned by Institutional Investors, 58.75% is owned by Insiders, and 7.10% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 28, 2025
xxxxxxxxxxxxx
$6000000
Nov 26, 2024
xxxxxxxxxxxxx
$9000
Nov 26, 2024
xxxxxxxxxxxxx
$8850
Nov 25, 2024
xxxxxxxxxxxxx
$22400

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$2544581
Mar 31, 2025
xxxxxxxxxxxxx
$2846203

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
99,209,612Insider43.45%45,934,050
34,093,007Insider14.93%15,785,062
8,646,365Institution3.79%4,003,267
7,236,843Institution3.17%3,350,658
7,231,398Institution3.17%3,348,137
6,310,873Institution2.76%2,921,934
6,291,196Institution2.75%2,912,824
5,642,088Institution2.47%2,612,287
1,632,230Institution0.71%755,722
1,609,804Institution0.70%745,339

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,231,398Institution3.17%3,348,137
1,632,230Institution0.71%755,722
1,609,804Institution0.70%745,339
894,040Institution0.39%413,941
820,126Institution0.36%379,718
417,900Institution0.18%193,488
416,223Institution0.18%192,711
128,266Institution0.06%59,387
93,589Institution0.04%43,332
70,884Institution0.03%32,819

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,416,552Institution1.93%2,203,859
4,367,667Institution1.91%2,022,230
3,179,388Institution1.39%1,586,515
1,557,102Institution0.68%720,938
889,398Institution0.39%443,810
358,474Institution0.16%165,973
357,676Institution0.16%821,939
251,928Institution0.11%578,931
161,027Institution0.07%80,352
103,800Institution0.05%48,838

FAQ

Who Owns Lineage Cell Therapeutics, Inc. (LCTX)?
According to the latest TipRanks data, approximately 0.02% of the company's stock is held by institutional investors, 58.75% is held by insiders, and 28.12% is held by retail investors.
    What percentage of Lineage Cell Therapeutics, Inc. (LCTX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.02% of Lineage Cell Therapeutics, Inc. (LCTX) stock is held by institutional investors.
      What percentage of Lineage Cell Therapeutics, Inc. (LCTX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 28.12% of Lineage Cell Therapeutics, Inc. (LCTX) stock is held by retail investors.
        Who owns the most shares of Lineage Cell Therapeutics, Inc. (LCTX)?
        Broadwood Partners Lp owns the most shares of Lineage Cell Therapeutics, Inc. (LCTX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis